Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
59,077,972
-
Shares change
-
-1,009,470
-
Total reported value, excl. options
-
$428,045,235
-
Value change
-
+$20,308,782
-
Put/Call ratio
-
30.4%
-
Number of buys
-
52
-
Number of sells
-
-62
-
Price
-
$7.24
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q3 2020
145 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q3 2020.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59,077,972 shares
.
Largest 10 shareholders include Avoro Capital Advisors LLC (10,300,000 shares), BlackRock Inc. (5,130,908 shares), BOXER CAPITAL, LLC (4,000,000 shares), VANGUARD GROUP INC (3,373,119 shares), BAKER BROS. ADVISORS LP (3,252,542 shares), CITADEL ADVISORS LLC (2,221,555 shares), Vivo Capital, LLC (2,089,356 shares), Invesco Ltd. (1,877,586 shares), Foresite Capital Management IV, LLC (1,787,094 shares), and Redmile Group, LLC (1,719,247 shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.